Publications by Researcher: Crespi, GAN

YearTitleAuthor(s)
2013 Bapineuzumab captures the N-terminus of the Alzheimer's disease amyloid-beta peptide in a helical conformation
Scientific Reports
Miles, LA Crespi, GAN Doughty, L Parker, MW
2014 Crystallization and preliminary X-ray diffraction analysis of the Fab portion of the Alzheimer's disease immunotherapy candidate bapineuzumab complexed with amyloid-beta
Acta Crystallographica Section F-structural Biology And Crystallization Communications
Crespi, GAN Ascher, DB Parker, MW Miles, LA
2014 Do current therapeutic anti-A beta antibodies for Alzheimer's disease engage the target?
Acta Neuropathologica
Watt, AD Crespi, GAN Down, RA Ascher, DB Gunn, A Perez, KA McLean, CA Villemagne, VL Parker, MW Barnham, KJ Miles, LA
2014 Anti-A beta antibody target engagement: a response to Siemers et al.
Acta Neuropathologica
Watt, AD Crespi, GAN Down, RA Ascher, DB Gunn, A Perez, KA McLean, CA Villemagne, VL Parker, MW Barnham, KJ Miles, LA
2015 Molecular basis for mid-region amyloid-beta capture by leading Alzheimer's disease immunotherapies
Scientific Reports
Crespi, GAN Hermans, SJ Parker, MW Miles, LA
2015 Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncated Abeta in sporadic Alzheimer disease cases and mouse models
Acta Neuropathol.
Bouter, Y Noguerola, JSL Tucholla, P Crespi, GAN Parker, MW Wiltfang, J Miles, LA Bayer, TA
2017 Ex vivo O-18-labeling mass spectrometry identifies a peripheral amyloid beta clearance pathway
Mol. Neurodegener.
Portelius, E Mattsson, N Pannee, J Zetterberg, H Gisslen, M Vanderstichele, H Gkanatsiou, E Crespi, GAN Parker, MW Miles, LA Gobom, J Blennow, K